Balanoposthitis

Back

Background

Balanoposthitis, defined as inflammation of the foreskin and glans in uncircumcised males, occurs over a wide age range and may have any of multiple bacterial or fungal origins or may be caused by contact dermatitides.[1]  Complex infections have been well documented, often from a poorly retractile foreskin and poor hygiene that leads to colonization and overgrowth. Balanoposthitis should not be confused with balanitis, which is inflammation of the glans penis or the clitoris.

Treatment focuses on clearing the acute infection and preventing recurrent inflammation or infection through improved hygiene. Circumcision, though not as necessary as in the past, may be considered for refractory or recurrent balanoposthitis. Consensus-based recommendations for care have been published.[2, 3]  (See Guidelines.)

Pathophysiology

Although multiple organisms have been incriminated in the pathogenesis of balanoposthitis, most patients are treated empirically, without confirmation of a specific causative organism. The multicausal origin of balanoposthitis was emphasized in a study that identified infectious, mechanical/traumatic, or contact dermatitides in 34 of 51 (67%) patients with mild balanoposthitis[4] ; in the remaining 17, no specific cause could be established even after clinical examination and microbiologic and serologic tests had been performed.

Candidal infection appears to be the most common cause of balanoposthitis.[5] In older men, other etiologic factors are often present, including intertrigo, irritant dermatitides, or other fungal infections. Organisms that have been identified include Bacteroides, Gardnerella,[6, 7] and Candida species, as well as beta-hemolytic streptococci.[8] Balanoposthitis may also occur as a manifestation of syphilis.[9, 10]

Although, in general, fungal infections of the penis are rare, it has been suggested that candidal balanitis/balanoposthitis is the most common mycotic infection of the penis.[11]  In one series, Candida species accounted for 30% of the causative organisms, with beta-hemolytic streptococci accounting for 13%. In another study, Candida species were identified as the causative pathogen in 50% of patients and Streptococcus species in 25%; no growth was noted in 13% (12% were not tested).[12]

Rare causes include Streptococcus pyogenes,[13, 14] Prevotella melaninogenica, Cordylobia anthropophaga,[15] Pasteurella bettyae,[16] Providencia stuartii, and Pseudomonas aeruginosa,[17] the last two in individuals who are immunocompromised. Reports of an association between human papillomavirus (HPV) infection and longstanding balanoposthitis have been published, but this association may be a noncausal one.[18, 19, 20] Associations with ulcerative colitis[21] and Crohn disease[22] have also been noted. Granulomatous balanoposthitis after intravesical bacille Calmette-Guérin (BCG) vaccine instillation has been described.[23]

Etiology

In a study by Alsterholm et al, patients with balanoposthitis had a significantly higher frequency of positive cultures than control subjects did (59% vs 35%).[24] In the balanoposthitis group, Staphylococcus aureus was found in 19% of patients, group B streptococci in 9%, Candida albicans in 18%, and Malassezia in 23%. In the control group, S aureus was not found at all, whereas C albicans was found in 7.7% of patients and Malassezia in 23%. Different causative organisms did not correspond with distinct clinical manifestations.

Although a direct causal relation has not been established, an association is known to exist between nonspecific balanoposthitis and the uncircumcised penis. Several authors have proposed that circumcision may protect against balanoposthitis and common penile infections.[25, 26]

Less common causes of balanoposthitis include external irritants or allergens (eg, contact-induced balanoposthitis caused by the application of celandine juice from the plant Chelidonium majus). An association with preputial smegma stones has been described, a correlation that most likely reflects the hygiene of the affected population.[27] Granulomatous balanoposthitis has occurred after intravesical BCG treatment of urothelial cancer.[28]  Fixed drug eruption–induced balanoposthitis has been reported.[29]

Epidemiology

United States and international statistics

To date, no studies of the incidence of balanoposthitis have been performed in the United States.

In a Japanese study, balanoposthitis was found in nine (1.5%) of 603 uncircumcised Japanese boys aged 0-15 years.[30] In a study from Hong Kong, only one of 2149 elementary schoolchildren had balanoposthitis.[31]  In a British study, Candida species were identified as the cause of balanoposthitis in 35% of 450 men examined.[32]  An Italian study found balanoposthitis in 51 (16%) of 321 patients with genital dermatoses.[4] A long-term Japanese study revealed an incidence of 3-7% per annum.[33]

Age-, sex-, and race-related demographics

Although balanoposthitis is known to occur over a wide age range, most studies have centered on the juvenile population (0-5 y) or on sexually active adult males.

By definition, balanoposthitis occurs only in males.

Although balanoposthitis, because of its heterogenous etiology, has been described in individuals of many races and ethnic backgrounds, no breakdowns of frequency on the basis of such categories have been performed.

Prognosis

The therapeutic outcome is often favorable, with treatment failures frequently leading to further clinical examination and tailoring of the treatment to the particular offending agent. Aside from the associated irritant symptoms, morbidity is limited.

Lack of response in the setting of appropriate treatment should raise the suspicion of malignancy.[34] Biopsy is then necessary to rule out both primary malignancies and secondary malignancies involving the penis. The most common malignancy that mimics balanoposthitis is erythroplasia of Queyrat, though Bowen disease may have some clinical overlap. A case report has described the presentation of acute promyelocytic leukemia as an ulcerating balanoposthitis.[35]  

Mondor phlebitis of the penis following recurrent candidal balanoposthitis has been reported.[36]

In a patient who is immunocompromised, the presence of a systemic fungal infection can lead to involvement of the penis and often arises as a more deeply involved ulcerating lesion. Treatment of this disease, which can be caused by any number of fungal agents, involves clearing the systemic infection and immunodepression. Mortality is present only in patients who are immunocompromised and develop balanoposthitis secondary to fungal bloodstream infection.

History

In adults, a detailed clinical history focusing on topical irritants and home remedies assists in making the correct diagnosis and in detecting possible contact dermatitides.

Patients with balanoposthitis may report varying degrees and types of sexual dysfunction.[37]

Physical Examination

Examination of the glans and the prepuce often reveals a red, moist macular lesion. Associated erythema is noted, and areas of yellow-to-black discoloration have been described.[38]  The presence of lichenification, irregular borders, or acetowhite changes with 5% acetic acid treatment suggest a human papillomavirus (HPV) infection, which can be seen in association with balanoposthitis.

A superimposed balanoposthitis on a flat condyloma has been described. Such coexisting lesions may be diagnosed on the basis of the clinical history and a culture of fungus or bacteria from the ulcer.

Ulceration and deep erosion have been seen in patients with advanced disease, often in association with fungal infections and in individuals who are immunocompromised.

Laboratory Studies

Potassium hydroxide (KOH) slide preparation allows rapid visualization of the candidal hyphae, and culture for Candida species often isolates candidal species and helps to direct proper treatment.

Rarely, serologic tests for candidal species may be indicated, particularly in unclear cases and for academic interest.

Procedures

Biopsy is performed in doubtful cases and when antifungal treatment fails to produce a favorable response. Biopsy is especially warranted if premalignant or malignant lesions, such as erythroplasia of Queyrat or Bowen disease, are suspected and must be excluded.

Histologic Findings

The histologic findings are nonspecific and eczematous in nature. Dermis contains lymphoplasmacytic infiltrates (see the image below). Special stains for fungi, such as the periodic acid–Schiff (PAS) stain, may exhibit fungal elements characteristic of candidal organisms.



View Image

Balanoposthitis. Dermis with lymphoplasmacytic infiltrates and dilated blood vessels.

Medical Care

The primary goals in the treatment of balanoposthitis are elimination of various pathogenic organisms and control of inflammation. Topical antibiotics (eg, metronidazole cream) and antifungals (eg, clotrimazole cream) or low-potency steroid creams for contact dermatitides often lead to clearing of the lesion.[43, 44, 45]

Proper hygiene with frequent washing and drying of the prepuce is an essential preventive measure.

Topical application of "water of the three sulfates" (copper sulfate, zinc sulfate, and alum) has been reported to be effective.[46]

Consensus-based guidelines and recommendations for care have been published.[2, 3]  (See Guidelines.)

Surgical Care

Circumcision or preputioplasty may be advocated in recurrent and recalcitrant cases.[47]

Prevention

Prevention has centered on improved hygiene of the prepuce. Although circumcision has been advocated for refractory or recurrent cases, it is now primarily used when improved drying and hygiene are not effective. Several authors have proposed that circumcision may protect against balanoposthitis and common penile infections.[25, 26]

European Guidelines for Management of Balanoposthitis

In 2023, a European group published updated guidelines for the management of various forms of balanoposthitis.[2]

Regimens for the management of balanoposthitis caused by Candida included the following:

Regimens for the management of balanoposthitis caused by anaerobic infection included the following:

Regimens for the management of balanoposthitis caused by aerobic infection included the following:

Regimens for the management of irritant/allergic balanoposthitis included the following:

Clotrimazole topical (Gyne Lotrimin, Lotrimin, Lotrimin AF)

Clinical Context: 

Miconazole topical (Cavilon Antifungal Cream, Desenex, Fungoid Tincture)

Clinical Context: 

Nystatin topical (Mycostatin topical, Nystop, Pediaderm AF)

Clinical Context: 

Fluconazole (Diflucan)

Clinical Context: 

Amoxicillin/clavulanate (Augmentin, Augmentin ES-600, Augmentin XR)

Clinical Context: 

Metronidazole topical (MetroCream, MetroGel, MetroLotion)

Clinical Context: 

Mupirocin (Bactroban, Bactroban Nasal, Centany)

Clinical Context: 

What is balanoposthitis?What is the pathophysiology of balanoposthitis?What causes balanoposthitis?What is the prevalence of balanoposthitis in the US?What is the global prevalence of balanoposthitis?What is the racial predilection of balanoposthitis?What is the sexual predilection of balanoposthitis?Which age groups have the highest prevalence of balanoposthitis?What is the prognosis of balanoposthitis?What is the focus of clinical history for the evaluation of balanoposthitis?Which physical findings are characteristic of balanoposthitis?Which conditions should be included in the differential diagnoses of balanoposthitis?What are the differential diagnoses for Balanoposthitis?What is the role of lab testing in the workup of balanoposthitis?What is the role of imaging studies in the workup of balanoposthitis?What is the role of serologic testing in the workup of balanoposthitis?What is the role of biopsy in the workup of balanoposthitis?Which histologic findings are characteristic of balanoposthitis?How is balanoposthitis treated?What is the role of surgery in the treatment of balanoposthitis?How is balanoposthitis prevented?Which medications are used in the treatment of balanoposthitis?Which medications in the drug class Antifungals, Systemic are used in the treatment of Balanoposthitis?Which medications in the drug class Antifungals, Topicals are used in the treatment of Balanoposthitis?

Author

Vladimir O Osipov, MD, Pathologist In Charge, QML Townsville

Disclosure: Nothing to disclose.

Coauthor(s)

Milton W Datta, MD, Assistant Professor, Departments of Pathology, Urology, and Hematology-Oncology, Emory University School of Medicine

Disclosure: Nothing to disclose.

Peter Langenstroer, MD, Associate Professor, Department of Urology, Medical College of Wisconsin

Disclosure: Nothing to disclose.

Scott M Acker, MD, Associate Professor, Director of Dermatopathology, Departments of Dermatology and Pathology, University of Alabama at Birmingham

Disclosure: Nothing to disclose.

Specialty Editors

Michael J Wells, MD, FAAD, Dermatologic/Mohs Surgeon, The Surgery Center at Plano Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Abdul-Ghani Kibbi, MD, FACP, Professor and Chair, Department of Dermatology, American University of Beirut Medical Center, Lebanon

Disclosure: Nothing to disclose.

References

  1. Tønne B, Ingvaldsen CA, Stubhaug V, Randjelovic I. Balanoposthitis. Tidsskr Nor Laegeforen. 2023 Nov 7. 143 (16):[View Abstract]
  2. [Guideline] Edwards SK, Bunker CB, van der Snoek EM, van der Meijden WI. 2022 European guideline for the management of balanoposthitis. J Eur Acad Dermatol Venereol. 2023 Jun. 37 (6):1104-1117. [View Abstract]
  3. [Guideline] Zhang L, Abdulrahman AAA, Guo H, Zhang J, Gao X, Pan W, et al. Chinese expert consensus on the diagnosis and treatment of balanoposthitis. Chin Med J (Engl). 2024 Jul 5. 137 (13):1519-1521. [View Abstract]
  4. Fornasa CV, Calabrŏ A, Miglietta A, Tarantello M, Biasinutto C, Peserico A. Mild balanoposthitis. Genitourin Med. 1994 Oct. 70 (5):345-6. [View Abstract]
  5. Chen J, Zhou YX, Jin XD, Chen SW. Expression of interleukin-2 in Candidal balanoposthitis and its clinical significance. Chin Med J (Engl). 2011 Sep. 124 (17):2776-8. [View Abstract]
  6. Burdge DR, Bowie WR, Chow AW. Gardnerella vaginalis-associated balanoposthitis. Sex Transm Dis. 1986 Jul-Sep. 13 (3):159-62. [View Abstract]
  7. Kinghorn GR, Jones BM, Chowdhury FH, Geary I. Balanoposthitis associated with Gardnerella vaginalis infection in men. Br J Vener Dis. 1982 Apr. 58 (2):127-9. [View Abstract]
  8. Norimatsu Y, Ohno Y. Streptococcus pyogenes balanoposthitis. IDCases. 2020. 21:e00832. [View Abstract]
  9. Rovira-López R, García-Martínez P, Martín-Ezquerra G, Pujol RM, Aventín DL. Balanoposthitis and Penile Edema: Atypical Manifestations of Primary Syphilis. Sex Transm Dis. 2015 Sep. 42 (9):524-5. [View Abstract]
  10. Mainetti C, Scolari F, Lautenschlager S. The clinical spectrum of syphilitic balanitis of Follmann: report of five cases and a review of the literature. J Eur Acad Dermatol Venereol. 2016 Oct. 30 (10):1810-1813. [View Abstract]
  11. Mayser P. Mycotic infections of the penis. Andrologia. 1999. 31 Suppl 1:13-6. [View Abstract]
  12. Wakatsuki A. [Clinical experience of streptococcal balanoposthitis in 47 healthy adult males]. Hinyokika Kiyo. 2005 Nov. 51 (11):737-40. [View Abstract]
  13. Füzi M, Csizik E, Gubacs G. [Balanoposthitis caused by Streptococcus pyogenes following sexual intercourse]. Orv Hetil. 1984 Jan 22. 125 (4):217-9. [View Abstract]
  14. Minami M, Wakimoto Y, Matsumoto M, Matsui H, Kubota Y, Okada A, et al. Characterization of Streptococcus pyogenes isolated from balanoposthitis patients presumably transmitted by penile-oral sexual intercourse. Curr Microbiol. 2010 Aug. 61 (2):101-5. [View Abstract]
  15. Petersen CS, Zachariae C. Acute balanoposthitis caused by infestation with Cordylobia anthropophaga. Acta Derm Venereol. 1999 Mar. 79 (2):170. [View Abstract]
  16. Li A, Herms F, Pataut D, Louison JB, Cassius C, Merimèche M, et al. Pasteurella bettyae Infections in Men Who Have Sex with Men, France. Emerg Infect Dis. 2024 Jul. 30 (7):1475-1477. [View Abstract]
  17. Lincopan N, Neves P, Mamizuka EM, Levy CE. Balanoposthitis caused by Pseudomonas aeruginosa co-producing metallo-beta-lactamase and 16S rRNA methylase in children with hematological malignancies. Int J Infect Dis. 2010 Apr. 14 (4):e344-7. [View Abstract]
  18. Birley HD, Luzzi GA, Walker MM, Ryait B, Taylor-Robinson D, Renton AM. The association of human papillomavirus infection with balanoposthitis: a description of five cases with proposals for treatment. Int J STD AIDS. 1994 Mar-Apr. 5 (2):139-41. [View Abstract]
  19. Petersen CS, Larsen J, Albrectsen JM. [Human papillomavirus--(HPV)/balanoposthitis--a new disease?]. Ugeskr Laeger. 1991 Apr 1. 153 (14):1000-1. [View Abstract]
  20. Wikström A, von Krogh G, Hedblad MA, Syrjänen S. Papillomavirus-associated balanoposthitis. Genitourin Med. 1994 Jun. 70 (3):175-81. [View Abstract]
  21. Lyttle PH. Ulcerative colitis and balanoposthitis. Int J STD AIDS. 1994 Jan-Feb. 5 (1):72-3. [View Abstract]
  22. Wijesurendra CS, Singh G, Manuel AR, Morris JA. Balanoposthitis--an unusual feature of Crohn's disease?. Int J STD AIDS. 1993 May-Jun. 4 (3):184. [View Abstract]
  23. Yusuke H, Yoshinori H, Kenichi M, Akio H. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy. Int J Urol. 2006 Oct. 13 (10):1361-3. [View Abstract]
  24. Alsterholm M, Flytström I, Leifsdottir R, Faergemann J, Bergbrant IM. Frequency of bacteria, Candida and malassezia species in balanoposthitis. Acta Derm Venereol. 2008. 88 (4):331-6. [View Abstract]
  25. Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, et al. Circumcision and genital dermatoses. Arch Dermatol. 2000 Mar. 136 (3):350-4. [View Abstract]
  26. Morris BJ, Krieger JN. Penile Inflammatory Skin Disorders and the Preventive Role of Circumcision. Int J Prev Med. 2017. 8:32. [View Abstract]
  27. Sonnex C, Croucher PE, Dockerty WG. Balanoposthitis associated with the presence of subpreputial "smegma stones". Genitourin Med. 1997 Dec. 73 (6):567. [View Abstract]
  28. Linden-Castro E, Pelayo-Nieto M, Alias-Melgar A. Penile tuberculosis after intravesical bacille Calmette-Guérin immunotherapy. Urology. 2014 Aug. 84 (2):e3. [View Abstract]
  29. Zhang J, Yang F, Wang M, Yang A, Zhang F, Xiao Y, et al. Fixed drug eruption-induced balanoposthitis: a case report. Int J Impot Res. 2024 Sep. 36 (6):553-555. [View Abstract]
  30. Kayaba H, Tamura H, Kitajima S, Fujiwara Y, Kato T, Kato T. Analysis of shape and retractability of the prepuce in 603 Japanese boys. J Urol. 1996 Nov. 156 (5):1813-5. [View Abstract]
  31. Hsieh TF, Chang CH, Chang SS. Foreskin development before adolescence in 2149 schoolboys. Int J Urol. 2006 Jul. 13 (7):968-70. [View Abstract]
  32. Dockerty WG, Sonnex C. Candidal balano-posthitis: a study of diagnostic methods. Genitourin Med. 1995 Dec. 71 (6):407-9. [View Abstract]
  33. Kato S, Ohnishi S, Saka T, Nakajima H, Tanda H. [Clinical statistics on outpatients during the 5 years period (from 1978 Nov. 1st to 1983 Dec. 31st) after the opening of the Urological Clinic of East Sapporo Sanjukai Hospital (II)]. Hinyokika Kiyo. 1984 Nov. 30 (11):1677-84. [View Abstract]
  34. Guliani A, Kumar S, Aggarwal D, Kumaran MS. Genital Lichen Sclerosus Et Atrophicus: A Benign Skin Disorder With Malignant Aftermath. Urology. 2018 Jul. 117:e7-e8. [View Abstract]
  35. Steinbach F, Essbach U, Florschütz A, Gruss A, Allhoff EP. Ulcerative balanoposthitis as the initial manifestation of acute promyelocytic leukemia. J Urol. 1998 Oct. 160 (4):1430-1. [View Abstract]
  36. Agrawal SK, Singal A, Pandhi D. Mondor's phlebitis of penis following recurrent candidal balanoposthitis. Int J Dermatol. 2005 Jan. 44 (1):83-4. [View Abstract]
  37. Dhillon SS, Dhaliwal R, Dev K, Mehmi N. Sexual Dysfunction Evaluation in Candidal Balanoposthitis: A Single Centred Observational Study. J Family Reprod Health. 2023 Mar. 17 (1):8-13. [View Abstract]
  38. Duerden BI. Black-pigmented gram-negative anaerobes in genito-urinary tract and pelvic infections. FEMS Immunol Med Microbiol. 1993 Mar. 6 (2-3):223-7. [View Abstract]
  39. Wollina U. Ablative erbium:YAG laser treatment of idiopathic chronic inflammatory non-cicatricial balanoposthitis (Zoon's disease)--a series of 20 patients with long-term outcome. J Cosmet Laser Ther. 2010 Jun. 12 (3):120-3. [View Abstract]
  40. Arumainayagam JT, Sumathipala AH, Smallman LA, Shahmanesh M. Flat condylomata of the penis presenting as patchy balanoposthitis. Genitourin Med. 1990 Aug. 66 (4):251-3. [View Abstract]
  41. Hejase MJ, Bihrle R, Castillo G, Coogan CL. Amebiasis of the penis. Urology. 1996 Jul. 48 (1):151-4. [View Abstract]
  42. Val-Bernal JF, Azcarretazábal T, Garijo MF. Pilonidal sinus of the penis. A report of two cases, one of them associated with actinomycosis. J Cutan Pathol. 1999 Mar. 26 (3):155-8. [View Abstract]
  43. Cree GE, Willis AT, Phillips KD, Brazier JS. Anaerobic balanoposthitis. Br Med J (Clin Res Ed). 1982 Mar 20. 284 (6319):859-60. [View Abstract]
  44. Waugh MA, Evans EG, Nayyar KC, Fong R. Clotrimazole (Canesten) in the treatment of candidal balanitis in men. With incidental observations on diabetic candidal balanoposthitis. Br J Vener Dis. 1978 Jun. 54 (3):184-6. [View Abstract]
  45. Pandya I, Shinojia M, Vadukul D, Marfatia YS. Approach to balanitis/balanoposthitis: Current guidelines. Indian J Sex Transm Dis. 2014 Jul-Dec. 35 (2):155-7. [View Abstract]
  46. Gonzalvo V, Polo A, Serrallach F, Gutiérrez A, Peyri E. Clinical study of the effectiveness of the "water of the 3 sulfates" on balanitis and balanoposthitis. Actas Urol Esp. 2015 Mar. 39 (2):118-21. [View Abstract]
  47. Angotti R, Molinaro F, Ferrara F, Pellegrino C, Bindi E, Fusi G, et al. Preputialplasty: can be considered an alternative to circumcision? When, how, why? Experience of Italian centre. Gland Surg. 2018 Apr. 7 (2):228-233. [View Abstract]

Balanoposthitis. Dermis with lymphoplasmacytic infiltrates and dilated blood vessels.

Balanoposthitis. Dermis with lymphoplasmacytic infiltrates and dilated blood vessels.